Therefore, our data suggest that HOXA5 transcriptionally activates SPRY2 and subsequently inhibits the activation of MEK/ERK signaling, thereby suppressing the malignant properties of PCa. The gene discussed is MAP2K7; the disease is posterior cortical atrophy.